Icon
+91 94997 68112
Login Register

Quillivant XR - (5 mg/mL; Extended-release Oral Suspension)

Methylphenidate Hydrochloride Tris pharma
5 mg/mL; Extended-release Oral Suspension
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
None None
Indicated for the treatment of Attention Deficit Hyperactivity Disorder
Yes
******* ** *** ***** ** **** **** ** **** ******* '*** (***** **, ****); '***, '***, '***, , '***, '***, '*** *** ******** ** *** **, **** *** *** ************ *********. ******* *** ****** **** ***** **** ** **** **** ******* ** ******* *** *** *********. ********** **** ******* *********, ********** **** *** ** ********* ***** *** ***** ** ********* *** *** *****. ******* *** ** '***, '***, *** '*** ** ** **** ****. *****, **** **** ** *********** ** ** *** ********* ** ******* ** **** ** **** *******. *** **** *** ******** *** *** ****** ***** ********* **** ** ****** ** **** ******. ******* ****** ****** ****** *** **, **** ** ********* ** ***** *********.
Quillivant XR Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7
******* *** ********* *** ********* **** ** ** **** ** ** **** ** ** *** ********* *** *********
*** ****** ******* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ********* ***** **, **** **** ** ** **** ***** *** **, ****
*** ****** *** \ ********* **** **, **** ******* **** ***** *** **, ****
  1. *** *, **** : ******* ******** **** ***** *** **** ** **** ******* '***, '***, '***, '***, '***.
  2. *** **, **** : **** ***** * **** ******* ******* ** ******** ***** ** ** *** ******** ***** ** ********.
  3. *** **, **** : **** ****** ***** * **** ******* *** ** *** ***** **** ** **** ******* '***, '***, '***, '***, '***, '***, '***.
  4. *** **, **** : **** ***** * **** ******* ******* ** ******** ***** ** ******** ** ******* ***** **** ** **** ****** '***.
  5. *** **, **** : **** ***** * **** ******* ******* ** ******** ***** ** ******** ** ******* ***** **** ** **** ****** '***.
  6. *** *, **** : ********** *** ********* **** *** ***** *** ***** ** ********* *** *** *****.
  7. *** *, **** : ******* **** ** ****** **. '*** '*** *** '*** .

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.